NewsRx

Search our medical news database

Tuberculosis Vaccines

Researchers describe findings in Tuberculosis Vaccines studies

Published in TB and Outbreaks Week, January 17th, 2006

Tuberculosis Vaccines research advances have been reported from the United States, France and United Kingdom.

Study 1: Boosting with the Mycobacterium tuberculosis major secretory protein enhances the protective efficacy of M. bovis BCG vaccination against tuberculosis.

According to a study from the United States, "Tuberculosis continues to ravage humanity, killing two million people yearly. Most cases occur in areas of the world to which the disease is endemic, where almost everyone is vaccinated early in life with M. bovis BCG, the currently available vaccine against tuberculosis. Thus, while more potent vaccines are needed to...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook